<unk> , also marketed under the name Redux, is a serotoninergic anorectic drug. It was for some years in the mid-1990s approved by the United States Food and Drug Administration for the purposes of weight loss. However, following multiple concerns about the cardiovascular side-effects of the drug, such approval was withdrawn. After it was removed in the US,<unk>  was also pulled out in other global markets. It was later superseded by sibutramine, which is a safer alternative to both<unk>  and fenfluramine.
The drug was manufactured by Interneuron Pharmaceuticals and marketed by Wyeth-Ayerst Laboratories. It is the enantiomer of levofenfluramine.
Dexfenfluramine
Dexchlorpheniramine
Levomepromazine
Methoxyphedrine
Levophenacylmorphan
Methdilazine
Dexbrompheniramine
Mephenoxalone